Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.245 USD | -2.26% |
|
-4.42% | -32.78% |
Capitalization | 68.48M 58.56M 54.55M 50.73M 93.74M 5.88B 104M 654M 250M 2.75B 257M 252M 10.09B | P/E ratio 2025 * |
-9.49x | P/E ratio 2026 * | -39.1x |
---|---|---|---|---|---|
Enterprise value | 5.24M 4.48M 4.17M 3.88M 7.17M 449M 7.96M 49.97M 19.11M 210M 19.64M 19.23M 772M | EV / Sales 2025 * |
0.02x | EV / Sales 2026 * | - |
Free-Float |
91.92% | Yield 2025 * |
0.3% | Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: PetMed Express, Inc.
More recommendations
More press releases
1 day | -2.56% | ||
1 week | -4.42% | ||
Current month | -2.41% | ||
1 month | -10.00% | ||
3 months | +7.28% | ||
6 months | -33.61% | ||
Current year | -32.78% |
1 week | 3.22 | ![]() | 3.5 |
1 month | 3.13 | ![]() | 3.67 |
Current year | 2.97 | ![]() | 5.58 |
1 year | 2.9 | ![]() | 6.85 |
3 years | 2.9 | ![]() | 24.01 |
5 years | 2.9 | ![]() | 57 |
10 years | 2.9 | ![]() | 57.8 |
Manager | Title | Age | Since |
---|---|---|---|
Sandra Campos
CEO | Chief Executive Officer | 58 | 2024-04-28 |
Robyn M. D'Elia
DFI | Director of Finance/CFO | 53 | 2024-09-15 |
Chief Operating Officer | - | 2024-06-02 |
Director | Title | Age | Since |
---|---|---|---|
Gian Fulgoni
CHM | Chairman | 77 | - |
Leslie Campbell
CHM | Chairman | 66 | 2024-01-04 |
Diana Purcel
BRD | Director/Board Member | 59 | 2022-04-03 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-2.26% | -4.42% | -15.84% | -84.84% | 68.48M | ||
-4.77% | -7.25% | -47.10% | -30.99% | 4.23B | ||
+0.34% | +2.19% | -0.55% | -25.73% | 1.33B | ||
+1.61% | +0.64% | +109.77% | +133.88% | 629M | ||
+1.32% | +4.22% | +26.38% | +36.69% | 484M | ||
-2.27% | -1.15% | 0.00% | -34.35% | 75.97M | ||
+16.07% | +21.36% | +22.87% | +18.61% | 71.48M | ||
Average | +1.39% | -0.59% | +13.65% | +1.90% | 983.51M | |
Weighted average by Cap. | -2.51% | -5.65% | -17.05% | -10.19% |
2025 * | 2026 * | |
---|---|---|
Net sales | 230M 197M 183M 171M 315M 19.75B 350M 2.2B 840M 9.25B 863M 845M 33.92B | 225M 192M 179M 166M 307M 19.27B 342M 2.14B 820M 9.02B 842M 825M 33.1B |
Net income | -7.32M -6.26M -5.83M -5.42M -10.02M -628M -11.13M -69.83M -26.7M -294M -27.44M -26.88M -1.08B | -1.8M -1.54M -1.43M -1.33M -2.46M -154M -2.73M -17.14M -6.55M -72.15M -6.74M -6.6M -265M |
Net Debt | -63.25M -54.08M -50.38M -46.85M -86.57M -5.43B -96.21M -604M -231M -2.54B -237M -232M -9.32B | -68.81M -58.84M -54.81M -50.97M -94.19M -5.9B -105M -657M -251M -2.76B -258M -253M -10.14B |
More financial data
* Estimated data
Employees
287
Sector
Drug Retailers
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-14 | 3.240 $ | -2.41% | 25,079 |
25-07-11 | 3.320 $ | -2.64% | 82,415 |
25-07-10 | 3.410 $ | -0.58% | 85,799 |
25-07-09 | 3.430 $ | -1.44% | 138,235 |
25-07-08 | 3.480 $ | +2.65% | 204,882 |
Delayed Quote Nasdaq, July 14, 2025 at 11:49 am
More quotesSell
Buy

Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
3.320USD
Average target price
3.350USD
Spread / Average Target
+0.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PETS Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition